Efectos adversos cutáneos del imatinib (inhibidor de la tirosín cinasa)
Author:
Publisher
Elsevier BV
Subject
Dermatology,Histology,Pathology and Forensic Medicine
Reference70 articles.
1. Molecularly targeted treatment for dermatofibrosarcoma protuberans;McArthur;Semin Oncol,2004
2. Imatinib for refractory chronic graft-versus-host disease with fibrotic features;Olivieri;Blood,2009
3. Therapeutic inhibition of tyrosine kinases in systemic sclerosis: A review of published experience on the first 108 patients treated with imatinib;Bournia;Semin Arthritis Rheum,2013
4. Tyrosine kinase inhibitors in the treatment of systemic mastocytosis;Ustun;Leuk Res,2011
5. KIT mutations in a series of melanomas and their impact on treatment with imatinib;Botella-Estrada;Actas Dermosifiliogr,2012
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lichenoid and psoriasiform drug induced rush during imatinib therapy: a clinical case;Almanac of Clinical Medicine;2024-01-18
2. Periocular hypopigmentation of the elderly (POHE): A case series;Journal of the European Academy of Dermatology and Venereology;2023-10-04
3. Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?;Clinics and Practice;2023-09-05
4. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management;Signal Transduction and Targeted Therapy;2023-07-07
5. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies;American Journal of Clinical Dermatology;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3